Atlas Trials

Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

Clinical trial NCT04546373 · COMPLETED

Trial details

NCT number
NCT04546373
Sponsor
Grupo Español de Investigación en Cáncer de Ovario
Status
COMPLETED
Study type
OBSERVATIONAL
Epithelial Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Start date
2020-09-30
Primary completion
2021-07-31
Enrollment
316

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.